Zdrowie i gospodarka · 10/01/2003
Pfizer Withdraws FDA Approval for Troglitazone Tablets
The FDA is withdrawing approval of a new drug application for REZULIN (troglitazone) Tablets, submitted by Pfizer, due to the product no longer being commercially available, thereby waiving the opportunity for a public hearing.